Edition:
United States

Epizyme Inc (EPZM.OQ)

EPZM.OQ on NASDAQ Stock Exchange Global Select Market

12.70USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$12.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
160,922
52-wk High
$20.40
52-wk Low
$9.35

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Mott

51 2016 Independent Chairman of the Board

Robert Bazemore

49 2015 President, Chief Executive Officer, Director

Susan Graf

44 2017 Chief Business Officer, Principal Financial Officer

Matthew Ros

50 2016 Chief Operating Officer

Peter Ho

55 2015 Executive Vice President, Chief Medical Officer